vidarabine has been researched along with nimustine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, M; Ishii, H; Ishii, Y; Kawano, H; Nakatsugawa, S; Satoh, K | 1 |
| Akita, Y; Asakura, H; Kosaka, N; Majima, H; Suzuki, N | 1 |
2 other study(ies) available for vidarabine and nimustine
| Article | Year |
|---|---|
[A trial of ACNU and radiation therapy with sensitizing agents for malignant gliomas].
Topics: Acyclovir; Adolescent; Adult; Aged; Brain Neoplasms; Bromodeoxyuridine; Combined Modality Therapy; Evaluation Studies as Topic; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Radiation Injuries; Radiation-Sensitizing Agents; Radiotherapy Dosage; Remission Induction; Vidarabine | 1989 |
[Enhancement of radiation response of SqII mouse tumors by combined treatment with misonidazole, vidarabine, and ACNU].
Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Combined Modality Therapy; Male; Mice; Misonidazole; Nimustine; Nitrosourea Compounds; Vidarabine | 1987 |